S
VVOS icon

SignatureFD’s Vivos Therapeutics VVOS Stock Holding History

SignatureFD’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$645 Hold
547
– – ﹤0.01% 3278
2025
Q4 		$1.11K Hold
547
– – ﹤0.01% 3102
2025
Q3 		$1.7K Hold
547
– – ﹤0.01% 2990
2025
Q2 		$1.73K Hold
547
– – ﹤0.01% 2909
2025
Q1 		$1.56K Hold
547
– – ﹤0.01% 2941
2024
Q4 		$2.35K Hold
547
– – ﹤0.01% 2824
2024
Q3 		$1.43K Hold
547
– – ﹤0.01% 2918
2024
Q2 		$1.21K Hold
547
– – ﹤0.01% 2870
2024
Q1 		$2.64K Hold
547
– – ﹤0.01% 2728
2023
Q4 		$6.8K Hold
547
– – ﹤0.01% 2411
2023
Q3 		$2.63K Hold
547
– – ﹤0.01% 2702
2023
Q2 		$6.97K Buy
+547
New +$5.36K ﹤0.01% 2396

Other funds holding VVOS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SignatureFD's VVOS Position: Q1 2026 in Review

SignatureFD held its Vivos Therapeutics (VVOS) position steady in Q1 2026 at 547 shares worth $645. The position accounts for ﹤0.01% of the portfolio, ranked #3278.

SignatureFD first reported a position in VVOS in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.97K in Q2 2023. 24 funds tracked by Wall St. Rank hold VVOS as of Q1 2026.

  • SignatureFD held 547 shares of Vivos Therapeutics worth $645 as of Q1 2026.
  • SignatureFD left its Vivos Therapeutics share count unchanged in Q1 2026.
  • Vivos Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #3278 holding.
  • SignatureFD first reported a position in Vivos Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • SignatureFD's Vivos Therapeutics position peaked at $6.97K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.